Allena Pharmaceuticals is Drug Discovery in United States that focus on Allena Pharmaceuticals Inc business. Founded in 2011. They cover business area such as Allena Pharmaceuticals Inc, class, patient, metabolic disorder, excess accumulation, certain metabolite, kidney stone, chronic kidney disease, CKD, end-stage renal disease, reloxaliase, hyperoxaluria, markedly elevated urinary oxalate level.
2011
( 13 years old in 2024 )
Allena Pharmaceuticals Inc
-
One Newton Executive Park
Suite 202
Newton, MA 02462
United States
Private
Allena Pharmaceuticals Incclasspatientmetabolic disorderexcess accumulationcertain metabolitekidney stonechronic kidney diseaseCKDend-stage renal diseasereloxaliasehyperoxaluriamarkedly elevated urinary oxalate level
* We use standard office opening hours in near Allena Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Allena Pharmaceuticals is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Allena Pharmaceuticals business is focusing on Allena Pharmaceuticals Inc.
Allena Pharmaceuticals headquarter office and corporate office address is located in One Newton Executive Park Suite 202 Newton, MA 02462 United States.
Allena Pharmaceuticals was founded in United States.
In 2024, Allena Pharmaceuticals is currently focus on Allena Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Allena Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Allena Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
